drugset / Trial / NCT02791373
Vinorelbine and Gemcitabine in Myeloma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the efficacy of gemcitabine is comparable with the efficacy of the standard chemotherapy with vinorelbine for mobilization of autologous stem cells in myeloma patients
Timeline
- Start
- 2014-03
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1250 mg/m2 | Intravenous |
| Comparator | Vinorelbine | Small molecule | 35 mg/m2 | Intravenous |